英哈
乙氧酰胺
支原体
牛分枝杆菌
异烟肼
结核分枝杆菌
生物
微生物学
基因
病毒学
肺结核
遗传学
抗生素
医学
链霉素
乙胺丁醇
病理
作者
Asesh Banerjee,Eugenie Dubnau,Annaïk Quémard,Venkataraman Balasubramanian,Kyung Sun Um,Theresa M. Wilson,Desmond M. Collins,Geoffrey de Lisle,William R. Jacobs
出处
期刊:Science
[American Association for the Advancement of Science]
日期:1994-01-14
卷期号:263 (5144): 227-230
被引量:1635
标识
DOI:10.1126/science.8284673
摘要
Isoniazid (isonicotinic acid hydrazide, INH) is one of the most widely used antituberculosis drugs, yet its precise target of action on Mycobacterium tuberculosis is unknown. A missense mutation within the mycobacterial inhA gene was shown to confer resistance to both INH and ethionamide (ETH) in M. smegmatis and in M. bovis. The wild-type inhA gene also conferred INH and ETH resistance when transferred on a multicopy plasmid vector to M. smegmatis and M. bovis BCG. The InhA protein shows significant sequence conservation with the Escherichia coli enzyme EnvM, and cell-free assays indicate that it may be involved in mycolic acid biosynthesis. These results suggest that InhA is likely a primary target of action for INH and ETH.
科研通智能强力驱动
Strongly Powered by AbleSci AI